CRU on Demand
Clinilabs Drug Development Corporation’s Phase I group provides sponsors with a unique CRU on Demand offering. When a CRU facility is needed for studies in rare patient population studies, we work with sponsors to identify investigators in the NY and NJ region who have access to such specialty populations, but who may not have access to inpatient research facilities.
Principal investigators are able to perform the outpatient portion of a clinical trial at their offices or clinics, and admit to Clinilabs’ Phase I unit for the inpatient portion of the trial. We have used this collaborative model successfully in a variety of rare disorders.
Drugs don’t work in patients who don’t take them
– C. Everett Koop, MD